Omnix Medical is a clinical company, dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains, a highly common problem in today's medicine especially in chronic conditions and in modern hospitals. These agents are based on natural antimicrobial peptides, genetically engineered to be compatible for therapeutic use. Omnix is addressing an enormous and rapidly growing market opportunity, represented by millions of Americans and many more millions worldwide, who suffer from infections associated with resistant bacteria.